Bridgeworth LLC bought a new stake in shares of Markel Co. (NYSE:MKL) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 186 shares of the insurance provider’s stock, valued at approximately $215,000.
Several other large investors have also made changes to their positions in MKL. Aevitas Wealth Management Inc. purchased a new position in shares of Markel during the fourth quarter valued at approximately $108,000. First Personal Financial Services boosted its position in shares of Markel by 156.1% during the fourth quarter. First Personal Financial Services now owns 105 shares of the insurance provider’s stock valued at $120,000 after buying an additional 64 shares during the period. SeaCrest Wealth Management LLC purchased a new position in shares of Markel during the fourth quarter valued at approximately $122,000. Cigna Investments Inc. New purchased a new position in shares of Markel during the fourth quarter valued at approximately $201,000. Finally, Homrich & Berg purchased a new position in shares of Markel during the fourth quarter valued at approximately $203,000. Institutional investors and hedge funds own 76.26% of the company’s stock.
Shares of Markel opened at $1,134.68 on Friday, according to MarketBeat.com. The company has a quick ratio of 0.59, a current ratio of 0.59 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $15.82 billion, a P/E ratio of 313.45 and a beta of 0.89. Markel Co. has a 52-week low of $949.72 and a 52-week high of $1,194.98.
Several brokerages have issued reports on MKL. Zacks Investment Research upgraded Markel from a “hold” rating to a “strong-buy” rating and set a $1,300.00 target price for the company in a research report on Wednesday, May 2nd. Boenning Scattergood set a $1,250.00 price target on Markel and gave the company a “buy” rating in a report on Friday, April 27th. Argus initiated coverage on Markel in a report on Wednesday, April 11th. They issued a “hold” rating for the company. ValuEngine upgraded Markel from a “sell” rating to a “hold” rating in a report on Monday, April 2nd. Finally, William Blair upgraded Markel from a “market perform” rating to an “outperform” rating in a report on Monday, March 19th. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $1,237.50.
In related news, Vice Chairman Steven A. Markel sold 200 shares of the business’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $1,140.08, for a total value of $228,016.00. Following the completion of the sale, the insider now owns 105,840 shares in the company, valued at $120,666,067.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Alan I. Kirshner sold 100 shares of the company’s stock in a transaction on Monday, April 2nd. The stock was sold at an average price of $1,149.02, for a total value of $114,902.00. The disclosure for this sale can be found here. Insiders sold 1,590 shares of company stock valued at $1,819,552 in the last quarter. 2.53% of the stock is owned by company insiders.
Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.